Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?

Area of Science:

• Oncology
• Endocrinology
• Surgical Pathology

Background:

• Increasing incidence of differentiated thyroid cancer globally.
• Significant contribution of papillary thyroid microcarcinomas to this rise.
• Concerns regarding overdiagnosis and overtreatment of these small tumors.

Purpose of the Study:

• To evaluate the current management strategies for papillary thyroid microcarcinomas.
• To assess the risks and benefits of active surveillance versus immediate surgical intervention.
• To inform clinical decision-making for patients with low-risk thyroid microcarcinomas.

Main Methods:

• Review of recent epidemiological data on thyroid cancer incidence.
• Analysis of studies reporting outcomes for papillary thyroid microcarcinomas.
• Comparison of mortality, recurrence rates, and surgical complication risks.
• Evaluation of active surveillance protocols in selected patient cohorts.

Main Results:

• Papillary thyroid microcarcinomas account for approximately 50% of increased thyroid cancer diagnoses.
• Mortality rates for these microcarcinomas are low and stable, especially without lymph node or distant metastases.
• Surgical complications carry a persistent risk of 1-3%, even in specialized centers.
• Recurrence rates for papillary thyroid microcarcinomas are low, ranging from 1-5%.

Conclusions:

• Active surveillance with curative intent should be considered for properly selected patients with papillary thyroid microcarcinomas.
• Delaying active treatment until significant progression can mitigate treatment side-effects.
• Management decisions should weigh the low mortality and recurrence against surgical risks.